“…The chemical transformation of gelatin to GelMA provides a means to overcome a key limitation of gelatin namely, the dependence of its physical state on temperature; by covalently crosslinking the acrylate groups to realize a permanent shape. Therefore, most reported 3D bioprinting of complex structures require either fugitive phases, like poly(ε-caprolactone), carbohydrate glass, alginate, or Pluronic F127 [ 11 , 12 , 13 , 14 , 15 , 16 ], or post-processing like photo-crosslinking [ 17 , 18 ] or chemical crosslinking [ 19 , 20 , 21 ], which makes the fabrication complicated and highly demanding. Moreover, the addition of fugitive materials, crosslinking reagents and UV-light also introduces more variables that produce complexity, which might hinder the translation of these technologies to the clinical space, and additionally, residual fugitive phase and crosslinking chemistries can also present cytotoxicity.…”